Xia Yu 4
4 · Summit Therapeutics Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Xia Yu
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-02+200,000→ 235,000 totalExercise: $2.64Exp: 2034-01-02→ Common Stock (200,000 underlying) - Award
Stock Option (right to buy)
2024-01-02+35,000→ 35,000 totalExercise: $2.64Exp: 2034-01-02→ Common Stock (35,000 underlying)
Footnotes (3)
- [F1]The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date.
- [F2]Not applicable.
- [F3]The option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on January 2, 2025.